期刊文献+

老年非肌层浸润性膀胱癌经尿道电切术后吉西他滨膀胱灌注的疗效 被引量:29

Clinical observation of gemcitabine irrigation after transurethral resection of non-muscle invasive bladder tumor in gerontal patients
下载PDF
导出
摘要 目的探讨经尿道电切术后联合吉西他滨膀胱灌注治疗非肌层浸润性膀胱癌患者临床疗效、不良反应及对生存质量的影响。方法选取作者单位2013年2月至2016年2月收治的102例膀胱癌患者,年龄均> 60岁,且术后病理类型均为非肌层浸润性膀胱癌,随机分为观察组(n=50)和对照组(n=52)。两组患者均行经尿道电切术,术后观察组采用吉西他滨膀胱灌注,对照组采用吡柔比星膀胱灌注。观察比较两组术后复发情况、不良反应发生情况及患者生存质量。结果观察组1年复发率为6.0%,2年复发率10.0%,2年总复发率16.0%,均明显低于对照组的11.5%、25.0%和36.5%。治疗后两组患者生存质量均显著提高,差异具有统计学意义(P<0.001);且观察组得分明显高于对照组(P<0.001)。观察组发生尿频、尿痛及血尿等不良反应共18例,不良反应发生率36.0%,显著低于对照组的57.7%,差异有统计学意义(P<0.001)。结论老年非肌层浸润性膀胱肿瘤患者采用经尿道电切术联合吉西他滨灌注治疗可有效减少术后复发率及不良反应发生率,提高患者生存质量。 Objective To investigate the effect of transurethral resection combined with gemcitabine bladder perfusion in the treatment of non-muscular invasive bladder cancer.Methods A total of 102 non-muscleinvasive bladder cancer patients aged over 60 from February 2013 to February 2016 were involved and divided into experimental group(n=50)and control group(n=52)randomly.After treated with transurethral resection,the experimental group was given gemcitabine bladder perfusion and the control group pirarubicin bladder perfusion.Postoperative recurrence,adverse reactions and the quality of life of patients were observed and compared between two groups.Results Recurrence rate of the experimental group was 6.0% after one year and 10.0% after two years and the total recurrence rate in the two years was 16.0% which was significantly lower than that of the control group (11.5%,25.0% and 36.5%,respectively).The quality of life in the two groups was improved significantly after the treatment,and the difference was statistically significant(P < 0.001).The score of the quality of life in experimental group was significantly higher than that of the control group(P < 0.001).Adverse reactions such as urinary pain,hematuria or frequent urination were found in 18 patients in experimental group,with an incidence rate of adverse reaction of 36.0%,which was significantly lower than that of the control group(57.7%)and the difference was statistically significant(P < 0.001).Conclusion Transurethral electrotomy combined with gemcitabine perfusion in elderly patients with non-myoinvasive bladder tumor can effectively reduce postoperative recurrence rate and the incidence of adverse reactions and improve the quality of life of the patients.
作者 江冰华 曹全富 冯庆兴 JIANG Binghua;CAO Quanfu;FENG Qingxing(Department of Urology,Nanping First Hospital Affiliated to Fujian Medical University,Nanping 353000,China)
出处 《实用医学杂志》 CAS 北大核心 2019年第13期2125-2127,2132,共4页 The Journal of Practical Medicine
关键词 膀胱癌 非肌层浸润性 经尿道电切术 膀胱灌注 吉西他滨 吡柔比星 bladder cancer non muscle invasive transurethral resection of bladder tumor bladder irrigation gemcitabine pirarubicin
  • 相关文献

参考文献3

二级参考文献11

  • 1曹明,马辰凯,马俊,等.吉西他滨膀胱灌注治疗复发性浅表性膀胱肿瘤的安全性与有效性[J].中华肿瘤杂志,2011,33(5):385-387.
  • 2Sylvester RJ,van der Meijden AP,Oosterlinck W,et al. Predic- ting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables:a combined a- nalysis of 2596 patients from seven EORTC trials[J]. Eur Urol, 2006,49(3) :466 -467.
  • 3Lamm DL. Intravesical therapy for superficial bladder cancer: slow but steady progress [ J ]. J Clin Oneol, 2003,21 ( 23 ) : 4 259 -4 260.
  • 4Kawamura S, Fujioka T, Kubo T, et al. A course of pirarubicin vesical irrigation at thirty mg effectively prevents post-TUR re- currence of superficial bladder cancer[ J]. Gan To Kagaku Ryo- ho, 1996,23 (4) :465 - 470.
  • 5Dalbagni G, Russo P, Bochner B, et al. Phase I1 trial of intravesi- cal gemcitabine in bacille Calmette-Gu6rin-refractory transition- al cell carcinoma of the bladder [ J ]. J Clin Oncol, 2036,24 (18) :2 729 -2 734.
  • 6Di Lorenzo G,Perdont S,Damiano R,et al. Gemcitabine versus bacille Calmette-Gu6rin after initial baeille Calmette-Gu6rin fail- ure in non-muscle-invasive bladder cancer :a multieenter prospec- tive randomized trial[J]. Cancer,2010,116(8) :1 893 - 1 900.
  • 7Porena M, Del Zingaro M, Lazzeri M, et al. Bacillus Calmette- Gu6rin versus gemcitabine for intravesical therapy in high-risk superficial bladder cancer : a randomised prospective study [ J ]. Urol Int ,2010,84( 1 ) :23 - 27.
  • 8梁华民,齐文旭,张明.膀胱癌保留膀胱术后膀胱灌注药物的疗效观察[J].中国肿瘤临床与康复,2010,17(1):67-68. 被引量:9
  • 9马邦一,康健,叶敏,陈建华,张良.吡柔比星(THP)膀胱内灌注预防浅表性膀胱肿瘤术后复发的疗效观察[J].中国肿瘤临床与康复,2000,7(1):47-48. 被引量:12
  • 10瞿连喜,金建军,王继功,方祖军,丁强,张元芳.米托蒽醌灌注预防膀胱癌术后复发的疗效观察(附98例报告)[J].中华泌尿外科杂志,2002,23(3):167-168. 被引量:32

共引文献40

同被引文献240

引证文献29

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部